Log in to save to my catalogue

Patents; Researchers Submit Patent Application, "Osteoprotegerin Derived RANKL Inhibitor", for Appro...

Patents; Researchers Submit Patent Application, "Osteoprotegerin Derived RANKL Inhibitor", for Appro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1882270378

Patents; Researchers Submit Patent Application, "Osteoprotegerin Derived RANKL Inhibitor", for Approval (USPTO 20170073391)

About this item

Full title

Patents; Researchers Submit Patent Application, "Osteoprotegerin Derived RANKL Inhibitor", for Approval (USPTO 20170073391)

Publisher

Atlanta: NewsRx

Journal title

Chemicals & Chemistry, 2017, p.6308

Language

English

Publication information

Publisher

Atlanta: NewsRx

More information

Scope and Contents

Contents

From Washington, D.C., VerticalNews journalists report that a patent application by the inventors Lavrovsky, Yan (Del Mar, CA); Xu, Ting (Needham, MA); Kostareva, Irina (Stamford, CT); Archuadze, Shorena (Mitishchi, Moscow Region, RU); Ignatiev, Vasily (Moscow, RU); Samsonov, Mikhail (Moscow, RU); Repik, Alexey (Moscow, RU), filed on March 6, 2014,...

Alternative Titles

Full title

Patents; Researchers Submit Patent Application, "Osteoprotegerin Derived RANKL Inhibitor", for Approval (USPTO 20170073391)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1882270378

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1882270378

Other Identifiers

ISSN

1944-1517

How to access this item